APPLICATION
ANDA209554
TYPE
ANDA
ORIGINAL APPROVAL
2017-10-13
LATEST ACTION
2024-02-16
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
TOBRAMYCINDiscontinued
TOBRAMYCIN 300MG/5ML · SOLUTION · INHALATION
Approval history
2024-02-16Labeling · Supplement 1 · standardAP
2017-10-13UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.